Raphael Pharmaceutical
(OTC) RAPH
Raphael Pharmaceutical Financials at a Glance
Market Cap
$28.25M
Revenue (TTM)
$0.00
Net Income (TTM)
$1.47M
EPS (TTM)
$-0.07
P/E Ratio
-21.54
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.40
Volume
111
Open
$1.40
Price
$1.40
Volume
111
Open
$1.40
Previous Close
$1.40
Daily Range
$1.40 - $1.40
52-Week Range
$0.04 - $1.40
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.40
Volume
111
Open
$1.40
Previous Close
$1.40
Daily Range
$1.40 - $1.40
52-Week Range
$0.04 - $1.40
RAPH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Raphael Pharmaceutical
RAPH Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
79%
Return on Assets
-22%
Earnings Yield
-4.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$28.25M
Shares Outstanding
20.18M
Volume
111
Short Interest
0.00%
Avg. Volume
2.148
Financials (TTM)
Gross Profit
$0.00
Operating Income
$0.00
EBITDA
$0.00
Operating Cash Flow
$210.00K
Capital Expenditure
$0.00
Free Cash Flow
$210.00K
Cash & ST Invst.
$45.00K
Total Debt
$0.00
Raphael Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$28.25M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$322.00K
-29.8%
EBITDA
$315.00K
-26.5%
Quarterly Fundamentals
Net Cash
$45.00K
+304.5%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-21.62%
N/A
Return on Invested Capital
79.13%
N/A
Free Cash Flow
$142.00K
+34.6%
Operating Cash Flow
$142.00K
+34.9%